DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens™, a revolutionary optical lens implant for treating presbyopia today announced that it has treated over 50% of subjects in the second stage enrollment of its pivotal study. Presbia received FDA approval to commence the second stage of its pivotal study in February, and continues enrollment of subjects at eleven investigational sites acros
NEEDHAM, Mass. & PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Tyrogenex, a privately held company focused on the development of next-generation targeted therapeutics for cancer and ophthalmology, announced data from its phase 1 safety study of X-82 at ISOPT.
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, which develops drug therapies to treat eye diseases, to present July 10 at the International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) Clinical meeting in Berlin.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/gbr5bg/north_america) has announced the addition of the “North America Ophthalmology Cataract Surgery Devices Market by Sub-Market (Intraocular Lenses, Phacoemuls…
ORLANDO, Fla. & CHENNAI, India–(BUSINESS WIRE)–The Intraocular Implant and Refractive Society of India (IIRSI) awarded a Special Gold Medal to Nicholas T. Curtis, CEO of LENSAR, Inc., a global leader in next generation femtosecond laser technology for refractive cataract surgery, for his outstanding contribution to industry. The award was presented in Chennai at the IIRSI Conference by Dr. C. Vijaya Bhaskar, honorable Minister for Health, Medical Education and Family Welfare for the state of
ORLANDO, Fla. & DELHI, India–(BUSINESS WIRE)–Dr. Kamal Kapur Chooses LENSAR’s Advanced Femtosecond Cataract Platform To Launch Laser-Assisted Cataract Procedure Practice at Sharp Sight Centres in Delhi, India
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO: 4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, announced today that it has hired Roger Girard as Chief Strategy Officer. Having built 14 successful companies over the past 40 years in multiple industries, Girard brings deep experience in business management and will
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/5rfx92/retinitis) has announced the addition of the “Retinitis Pigmentosa (Retinitis)-API Insights” report to their offering. Retinitis Pigmentosa (Retinitis)-API…
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/wzsmx2/gene_therapy) has announced the addition of the “Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscap…
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/hshg6b/retinal_vein) has announced the addition of the “Retinal Vein Occlusion – Pipeline Review, H1 2015” report to their offering. This report provides comprehe…
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (the “Company”), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that Julie McHugh and Michael M. du Toit have been elected to the Company’s Board of Directors. Both individuals bring extensive senior healthcare-focused leadership experience, Ms. McHug
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/z46fl6/epicast_report) has announced the addition of the “EpiCast Report: Glaucoma – Epidemiology Forecast to 2023” report to their offering. Glaucoma is a common…
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today anno…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–John McCabe, Eleven’s VP, Finance and Business Operations, is promoted to assume the roles of Principal Financial Officer and Principal Accounting Officer, reporting directly to Abbie Celniker, PhD.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/t2fxnx/posterior_uveitis) has announced the addition of the “Posterior Uveitis – Pipeline Review, H1 2015” report to their offering. This report provides comprehe…
INDIANAPOLIS–(BUSINESS WIRE)–Renaissance is adding nationally recognized dental and vision plans in South Carolina with new hire, Dan Pruitt.
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida CEO to present at ISOPT clinical meeting in Berlin in July 2015
ALPHARETTA, Ga.–(BUSINESS WIRE)–Visioneering Technologies, Inc., (VTI), manufacturers of NaturalVue™ Multifocal 1 Day Daily Disposable Soft Contact Lenses, has tapped MidSouth Premier Ophthalmics as exclusive distributor
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced the presentation of integrated efficacy and tolerability data from its Phase III program with NUPLAZID™ (pimavanserin) at the 19th International Congress of Parkinson’s Disease and Movement Disorders held in San Diego. “Data from the integrated analysis o
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, Inc., a biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced a favorable End-of-Phase 2 review with the U.S. Food and Drug Admi…